A light-inducible RNA base editor for precise gene expression

1. Booth, B. J. et al. RNA editing: expanding the potential of RNA therapeutics. Mol. Ther. 31, 1533–1549 (2023). A review article that summarizes the emerging field of therapeutic RNA editing and discusses key challenges in clinical development.

   CAS 
   PubMed 
   PubMed Central 
   
   Google Scholar 

2. Teixeira, A. P. & Fussenegger, M. Synthetic gene circuits for regulation of next-generation cell-based therapeutics. Adv. Sci. 11, 1–24 (2024). A review article that presents examples of engineered genetic circuits applied to cell-based therapeutics.

   
   Google Scholar 

3. Song, J., Zhuang, Y. & Yi, C. Programmable RNA base editing via targeted modifications. Nat. Chem. Biol. 20, 277–290 (2024). A review article that summarizes some emerging RNA editors and discusses their limitations, opportunities and future directions.

   CAS 
   PubMed 
   
   Google Scholar 

4. Yu, J. et al. Programmable RNA base editing with photoactivatable CRISPR-Cas13. Nat. Commun. 15, 1–14 (2024). This paper reports a light-inducible RNA base editor that employs a photoactivatable split dCas13b in conjugation with intact ADAR2dd variant.

   
   Google Scholar 

5. Stroppel, A. S., Lappalainen, R. & Stafforst, T. Controlling site-directed RNA editing by chemically induced dimerization. Chemistry 27, 12300–12304 (2021). This paper reports a chemically inducible RNA base editor named the gibberellic acid (GA3)-induced SNAP-ADAR system.

   CAS 
   PubMed 
   PubMed Central 
   
   Google Scholar 

6. Anadón, C. et al. Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis. Oncogene 35, 4407–4413 (2016). This paper reports the carcinogenic risk of overexpressing ADAR proteins.

   PubMed 
   
   Google Scholar 

Download references

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Li, H. et al. Engineering a photoactivatable A-to-I RNA base editor for gene therapy in vivo. Nat. Biotechnol. https://doi.org/10.1038/s41587-025-02610-2 (2025).